SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-11-330317
Filing Date
2011-12-05
Accepted
2011-12-05 15:39:41
Documents
3
Period of Report
2011-12-05
Filing Date Changed
2011-12-05
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d265257d8k.htm 8-K 21597
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY d265257dex31.htm EX-3.1 6015
3 PRESS RELEASE d265257dex991.htm EX-99.1 10637
  Complete submission text file 0001193125-11-330317.txt   39724
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 111243017
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1